These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29769912)

  • 1. The Canadian Immunization Monitoring Program, ACTive (IMPACT): Active surveillance for vaccine adverse events and vaccine-preventable diseases.
    Bettinger JA; Halperin SA; Vaudry W; Law BJ; Scheifele DW;
    Can Commun Dis Rep; 2014 Dec; 40(Suppl 3):41-44. PubMed ID: 29769912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canada's eight-component vaccine safety system: A primer for health care workers.
    MacDonald NE; Law BJ
    Paediatr Child Health; 2017 Jul; 22(4):236. PubMed ID: 29479220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canada's eight-component vaccine safety system: A primer for health care workers.
    MacDonald NE; Law BJ
    Paediatr Child Health; 2017 Jul; 22(4):e13-e16. PubMed ID: 29507505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canadian vaccine research networks: Vaccine safety resources for Canada.
    McCarthy J; Halperin SA; Bettinger JA; Langley JM; Crowcroft NS; Deeks S; Kwong JC; De Serres G; Top K; McNeil S; Scheifele DW;
    Can Commun Dis Rep; 2015 Feb; 41(Suppl 1):18-23. PubMed ID: 29769957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse events following immunization in Ontario's female school-based HPV program.
    Harris T; Williams DM; Fediurek J; Scott T; Deeks SL
    Vaccine; 2014 Feb; 32(9):1061-6. PubMed ID: 24440208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paediatric Active Enhanced Disease Surveillance (PAEDS) annual report 2016: Prospective hospital-based surveillance for serious paediatric conditions.
    McRae JE; Quinn HE; Saravanos GL; McMinn A; Britton PN; Wood N; Marshall H; Macartney K
    Commun Dis Intell (2018); 2019 Feb; 43():. PubMed ID: 30727704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine vigilance in Canada: Is it as robust as it could be?
    Duclos P
    Can Commun Dis Rep; 2014 Dec; 40(Suppl 3):2-6. PubMed ID: 29769907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canada's Vaccine Vigilance Working Group.
    Ahmadipour N; Toth E; Law BJ
    Can Commun Dis Rep; 2014 Dec; 40(Suppl 3):37-40. PubMed ID: 29769911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge and Perceptions of Adverse Events Following Immunization among Healthcare Professionals in Africa: A Case Study from Ghana.
    Yamoah P; Bangalee V; Oosthuizen F
    Vaccines (Basel); 2019 Mar; 7(1):. PubMed ID: 30857257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine surveillance of adverse events following immunization as an important tool to monitor vaccine safety.
    Alicino C; Merlano C; Zappettini S; Schiaffino S; Della Luna G; Accardo C; Gasparini R; Durando P; Icardi G
    Hum Vaccin Immunother; 2015; 11(1):91-4. PubMed ID: 25483520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surveillance system for adverse events following immunization against yellow fever in Burkina Faso in 2008. Good practice recommendations].
    Yaméogo TM; Breugelmans JG; Kambou JL; Badolo O; Tiendrebéogo S; Traoré E; Avokey F; Yactayo S
    Med Trop (Mars); 2009 Aug; 69(4):320-1. PubMed ID: 19725376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse Events Following Immunization in Brazil: Age of Child and Vaccine-Associated Risk Analysis Using Logistic Regression.
    Lopes SRC; Perin JLR; Prass TS; Carvalho SMD; Lessa SC; Dórea JG
    Int J Environ Res Public Health; 2018 Jun; 15(6):. PubMed ID: 29865181
    [No Abstract]   [Full Text] [Related]  

  • 13. Paediatric Active Enhanced Disease Surveillance inaugural annual report, 2014.
    Zurynski YA; McRae JE; Quinn HE; Wood NJ; Macartney KK
    Commun Dis Intell Q Rep; 2016 Sep; 40(3):E391-E400. PubMed ID: 28278415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving community based AEFI (Adverse Events Following Immunization) reporting rate through telephone "beep" in a Cameroon health district: a randomized field trial.
    Tsafack M; Ateudjieu J
    Pan Afr Med J; 2015; 22():351. PubMed ID: 26985269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance of adverse events following immunization in China: Past, present, and future.
    Liu D; Wu W; Li K; Xu D; Ye J; Li L; Wang H
    Vaccine; 2015 Jul; 33(32):4041-6. PubMed ID: 25936727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annual report: surveillance of adverse events following immunisation in Australia, 2008.
    Menzies R; Mahajan D; Gold MS; Roomiani I; McIntyre P; Lawrence G
    Commun Dis Intell Q Rep; 2009 Dec; 33(4):365-81. PubMed ID: 20301966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behind the scenes in public health: Adverse events following immunization (AEFI) signal investigation in British Columbia.
    MacDonald L; Naus M
    Can Commun Dis Rep; 2014 Dec; 40(Suppl 3):24-30. PubMed ID: 29769909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse events following immunization (AEFI) with the novel influenza a (H1N1) 2009 vaccine: findings from the national registry of all vaccine recipients and AEFI and the passive surveillance system in South Korea.
    Kim JH; Cho HY; Hennessey KA; Lee HJ; Bae GR; Kim HC
    Jpn J Infect Dis; 2012; 65(2):99-104. PubMed ID: 22446114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surveillance of adverse events following immunization in Minhang district of Shanghai from 2007 to 2010].
    Zhang LP; Yu F; Jin BF; Wang Y; Xu HL; DU Y
    Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):859-64. PubMed ID: 23302620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse events following immunization: real causality and myths.
    Principi N; Esposito S
    Expert Opin Drug Saf; 2016 Jun; 15(6):825-35. PubMed ID: 26986067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.